4/7
04:05 pm
acrv
Form 8-K Acrivon Therapeutics, For: Apr 07
Low
Report
Form 8-K Acrivon Therapeutics, For: Apr 07
4/3
04:33 pm
acrv
Form 4 Acrivon Therapeutics, For: Apr 01 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Apr 01 Filed by: Miller Mary
4/3
04:31 pm
acrv
Form 4 Acrivon Therapeutics, For: Apr 01 Filed by: Levy Adam D.
Medium
Report
Form 4 Acrivon Therapeutics, For: Apr 01 Filed by: Levy Adam D.
4/3
04:29 pm
acrv
Form 3 Acrivon Therapeutics, For: Apr 01 Filed by: Levy Adam D.
Medium
Report
Form 3 Acrivon Therapeutics, For: Apr 01 Filed by: Levy Adam D.
3/28
09:08 am
acrv
Form S-8 Acrivon Therapeutics,
High
Report
Form S-8 Acrivon Therapeutics,
3/27
04:48 pm
acrv
Form 8-K Acrivon Therapeutics, For: Mar 27
High
Report
Form 8-K Acrivon Therapeutics, For: Mar 27
3/27
04:08 pm
acrv
Form 10-K Acrivon Therapeutics, For: Dec 31
High
Report
Form 10-K Acrivon Therapeutics, For: Dec 31
3/25
05:16 pm
acrv
Form 8-K Acrivon Therapeutics, For: Mar 25
High
Report
Form 8-K Acrivon Therapeutics, For: Mar 25
3/14
04:45 pm
acrv
Form 8-K Acrivon Therapeutics, For: Mar 11
Low
Report
Form 8-K Acrivon Therapeutics, For: Mar 11
3/4
05:37 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Peterson Katharine
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Peterson Katharine
3/4
05:32 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary
3/4
05:29 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Holm-Jorgensen Rasmus
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Holm-Jorgensen Rasmus
3/4
05:24 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Gamelin Erick
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Gamelin Erick
3/4
05:22 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric
3/4
05:14 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Cuillerot Jean-Marie
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Cuillerot Jean-Marie
3/4
05:12 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Blume-Jensen Peter
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Blume-Jensen Peter
2/25
04:10 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 21 Filed by: Blume-Jensen Peter
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 21 Filed by: Blume-Jensen Peter
2/19
05:00 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Peterson Katharine
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Peterson Katharine
2/19
04:59 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
2/19
04:55 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
2/19
04:55 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Holm-Jorgensen Rasmus
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Holm-Jorgensen Rasmus
2/19
04:54 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Devroe Eric
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Devroe Eric
2/19
04:53 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Blume-Jensen Peter
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Blume-Jensen Peter
1/22
04:16 pm
acrv
Form 4 Acrivon Therapeutics, For: Jan 17 Filed by: Miller Mary
Low
Report
Form 4 Acrivon Therapeutics, For: Jan 17 Filed by: Miller Mary